Kojo Elenitoba-Johnson, MD

Peter C. Nowell, M.D., Professor
University of Pennsylvania Perelman School of Medicine
Director, Center for Personalized Diagnostics
Director, Division of Precision and Computational Diagnostics

Contact InformationDepartment of Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania
609 Stellar-Chance
422 Curie Blvd.
Philadelphia, PA, 19104-6100
Office: 215-898-8198
Fax: 215-898-9969

Specialty Division

Precision and Computational Diagnostics

Itmat Expertise

Molecular pathogenesis, biomarkers and therapeutic targets of malignant lymphoid neoplasia


MD (Medicine), College of Medicine, University of Lagos and Lagos University Teaching Hospital, 1988

Specialty Certification

Educational Commission for Foreign Medical Graduates Certification (ECFMG), 1988
Diplomate of American Board of Pathology (Combined Anatomic Pathology and
Clinical Pathology), 1996
New York State Certification of Qualification for Molecular Oncology and Hematopathology, 1998
Diplomate of American Board of Pathology (Hematology), 1998
Diplomate of American Board of Pathology (Molecular Genetic Pathology), 2001
New York State Department of Health, Certificate of Qualification for Laboratory Director for Hematology, Histopathology General and Oncology Molecular and Cellular Tumor Markers, 2008

Postgraduate Training

Residency, Anatomic and Clinical Pathology, Brown University School of Medicine, Providence, Rhode Island, 1991-1995
Chief Resident, Department of Pathology, Brown University School of Medicine, Providence, RI, 1992-1994
Fellowship, Hematopathology, Lab of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, 1995-1997
Leadership Development for Physicians in Academic Health Centers, Harvard School of Public Health, Cambridge, MA, 2012-2012
Linkage Leadership Academy, University of Michigan, MA, 2013-2013

Awards and Honors

“Concepts in Molecular Pathology”, American Society of Investigative Pathology Scholarship, 1993
Outstanding Graduating Resident Award, Brown University Residency Training Program, 1995
Pathologist in Training Award, Society for Hematopathology, 1998
Outstanding Teaching Award in Anatomic Pathology, University of Utah Department of
Pathology, 1999
Outstanding Teaching Award in Anatomic Pathology, University of Utah Department of
Pathology, 2003
Best Doctors in America honoree, 2003-2018
Ramzi Cotran Young Investigator Award, United States and Canadian Academy of Pathology, 2006
Finalist, Burroughs Welcome Fund Clinical Scientist Award in Translational Research, 2007
Henry C. Bryant Endowed Professorship, Department of Pathology, University of Michigan, 2011
Elected Member, American Society for Clinical Investigation Society, 2011
League of Research Excellence, University of Michigan, 2011
American Society for Investigative Pathology Outstanding Investigator Award (formerly the
ASIP Amgen, Pfizer, Warner-Lambert-Parke-Davis Award), 2012
Elected Member, American Association of University Pathologists (PLUTO Society), 2013
Peter C. Nowell, M.D., Endowed Professorship, Perelman School of Medicine, University of Pennsylvania Health System, 2015
President-Elect/Association for Molecular Pathology, 2016-2017
Member nomination-December 2016 - John Morgan Society of the University of Pennsylvania, 2016
Member - Interurban Clinical Club, 2016

Memberships and Professional Organizations

American Society for Clinical Pathology, 1991 - Present
New England Pathology Residents’ Society, 1992 - 1993
United States and Canadian Academy of Pathology, 1995 - Present
American Society of Hematology, 1997 - Present
Association for Molecular Pathology, 1997 - Present
Society for Hematopathology/European Association for Haematopathology, 1998 - Present
American Society for Investigative Pathology, 2001 - Present
National Institutes of Health, National Cancer Institute, 2003 - Present
American Society for Biochemistry and Molecular Biology, 2005 - Present
Michigan Society of Pathologists, 2006 - Present
Lymphoma Research Foundation, 2007 - Present
Food and Drug Administration (FDA), 2008 - Present
Netherlands Cancer Institute, 2009 - 2009
National Institutes of Health Center for Scientific Review, 2010 - 2014
American Society of Clinical Investigation, 2011 - Present
National Institutes of Health, Bethesda, MD, 2013 - 2018
American Association for Cancer Research, 2014 - Present
International Lymphoma Study Group, 2015 - Present
Interurban Clinical Club, 2016 - Present
National Cancer Policy Forum of The National Academies of Sciences, Engineering and Medicine, 2017 - 2020

Web Links

Selected Publications

Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas.

Rolland DCM, Basrur V, Jeon YK, McNeil-Schwalm C, Fermin D, Conlon KP, Zhou Y, Ng SY, Tsou C-C, Brown NA, Thomas DG, Bailey NG, Omenn GS, Nesvizhskii AI, Weinstock DM, Faryabi RB, Lim MS, Elenitoba-Johnson KSJ, Proceedings of the National Academy of Sciences of the United States of America 114(25): 6581-6586, 2017, PMID:28607076

Read article

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic Multicentric Castleman disease

Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Shanmuganathan C, Lechowicz MJ, Wong RSM, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel C, Casper C, Dispenzieri A, Fossa A, Kelleher D, Kurzock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KSJ, Lim MS., Blood, 2017, PMID:28087540

Read article

Senescent stromal cell-induced divergence and therapeutic resistance in T-cell acute lymphoblastic leukemia/lymphoma.

Habiel DM, Krepostman N, Lilly M, Cavassani K, Coelho AL, Shibata T, Elenitoba-Johnson KSJ, Hogaboam CM., Oncotarget, 2016, PMID:27835864

Read article

NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.

Murga-Zamalloa CA, Mendoza-Reinoso V, Sahasrabuddher AA, Rolland DCM, Hwang SR, McDonnell SRP, Sciallis AP, Wilcox RA, Bashur V, Elenitoba-Johnson KSJ, Lim MS., Oncogene 36(15): 2085-2094, 2016, PMID:27694894

Read article

Activating KRAS mutations are characteristic of oncocytic sinonasal papilloma and associated sinonasal squamous cell carcinoma.

Udager AM, McHugh JB, Betz BL, Montone KT, Livolsi VA, Seethala RR, Yakirevich E, Iwenofu OH, Perez-Ordonez B, DuRoss KE, Weigelin HC, Lim MS, Elenitoba-Johnson KSJ, Brown NA, J Pathol 239(4): 394-8, 2016, PMID:27234382

Read article

FBXO11: a novel germinal center B-cell regulator

Elenitoba-Johnson KSJ, Blood, 2016, PMID:27492310

Read article

Precision medicine for diffuse large B-cell lymphoma.

Lim MS, Elenitoba-Johnson KSJ, Clin Cancer Res 22(12): 2829-31, 2016, PMID:26988247

Read article

Loss of the Ubiquitin-conjugating Enzyme Ube2W results in susceptibility to early postnatal lethality and defects in skin, immune and male reproductive systems.

Wang B, Merillat SA, Vincent M, Huber AK, Basrur V, Mangelberger D, Zeng L, Elenitoba-Johnson KSJ, Miller RA, Irani DN, Dlugosz AA, Schnell S, Scaglione KM, and Paulson HL., J Biol Chem, 2016

API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.

Rosebeck S, Lim MS, Elenitoba-Johnson KSJ, McAllister-Lucas LM, Lucas PC., World J Biol Chem. 7(1): 128-137, 2016, PMID:26981201

Read article

Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation.

Klinger M, Zheng J, Elenitoba-Johnson K S J, Perkins S L, Faham M, Bahler D W, Leukemia, 2015, PMID:26686246

Read article